Victory Capital Management’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$328K Buy
42,762
+4,718
+12% +$32.3K ﹤0.01% 2111
2025
Q4
$75.3K Buy
+38,044
New +$86.2K ﹤0.01% 2301
2025
Q2
Sell
-10,707
Closed -$32.2K 2509
2025
Q1
$32.2K Sell
10,707
-9,061
-46% -$27.5K ﹤0.01% 2397
2024
Q4
$50.6K Buy
19,768
+8
+0% +$33 ﹤0.01% 2394
2024
Q3
$73.5K Sell
19,760
-193
-1% -$893 ﹤0.01% 2356
2024
Q2
$126K Buy
19,953
+2,746
+16% +$18.1K ﹤0.01% 2267
2024
Q1
$92.4K Sell
17,207
-435
-2% -$1.97K ﹤0.01% 2314
2023
Q4
$88.6K Buy
17,642
+3,613
+26% +$11.3K ﹤0.01% 2365
2023
Q3
$23.7K Buy
+14,029
New +$28.2K ﹤0.01% 2438
2022
Q3
Sell
-11,741
Closed -$44K 2731
2022
Q2
$44K Sell
11,741
-75
-0.6% -$301 ﹤0.01% 2561
2022
Q1
$43K Buy
11,816
+248
+2% +$1.52K ﹤0.01% 2607
2021
Q4
$70K Sell
11,568
-13,890
-55% -$104K ﹤0.01% 2621
2021
Q3
$248K Buy
25,458
+1,033
+4% +$11.4K ﹤0.01% 2446
2021
Q2
$349K Sell
24,425
-11,228
-31% -$185K ﹤0.01% 2363
2021
Q1
$846K Buy
35,653
+4,098
+13% +$106K ﹤0.01% 1982
2020
Q4
$421K Buy
+31,555
New +$304K ﹤0.01% 2157
2020
Q2
Sell
-11,246
Closed -$32K 2849
2020
Q1
$32K Buy
+11,246
New +$56.3K ﹤0.01% 2934
2019
Q4
Sell
-9,415
Closed -$11K 2916
2019
Q3
$11K Buy
+9,415
New +$11.7K ﹤0.01% 3227

Other funds holding IBRX